In the News

Lowering serum urate levels with allopurinol did not improve kidney outcomes in patients with type 1 diabetes

Randomized trial participants with type 1 diabetes and mild-to-moderate diabetic kidney disease who received allopurinol or placebo had similar estimated glomerular filtration rates after three years.

CGM improves glucose control in high-risk groups with type 1 diabetes, studies find

Continuous glucose monitoring (CGM) was associated with improved HbA1c levels among adolescents and young adults in one trial and less hypoglycemia among older adults in another.

Pain in diabetes-related polyneuropathy associated with adverse events, death

Patients with type 2 diabetes who had no diabetes-related polyneuropathy, diabetes-related polyneuropathy with pain, and diabetes-related polyneuropathy without pain were compared in an industry-funded retrospective study.

MKSAP quiz: Diabetes screening

This month's quiz asks readers to evaluate a 40-year-old man who is healthy and asymptomatic but has some risk factors for diabetes.

Spotlight on young-onset type 2 diabetes

Some recent studies investigated cardiovascular disease, mortality risk, kidney disease, and the evidence base among patients who develop type 2 diabetes before age 40 or 50 years.

Diabetes drug classes associated with similar outcomes in low-risk patients

A systematic review and network meta-analysis found no differences between treatments for drug-naive patients with type 2 diabetes at low cardiovascular risk, leading the authors to conclude that metformin is justified as a first-line therapy.